Due Diligence

(Power)Point (not) taken

Kaoru Sakabe
June 1, 2017

For some authors, PowerPoint is the go-to software for preparing figures. Despite its popularity, PowerPoint has some serious shortcomings. Here, I will discuss why PowerPoint is not a good tool for illustrating your data. Instead, you should be using software dedicated to graphics editing, such as Illustrator or Inkscape, to ensure that figure quality is not compromised.

Due-Dilligence-Powerpoint.png Figure 1:  I’ve taken a 1000 ppi photo of my dog, Kim Chee, and converted it into a 72 ppi image, a scenario that would happen if you inserted your image into PowerPoint. To convert the PowerPoint into a 300 ppi TIFF, Photoshop will either resize or resample the image, and both processes may yield unusable images.

PowerPoint is a great program for making slide presentations. It’s just not so great for making figures. PowerPoint works at screen resolution, which is 72 ppi. So when you export or save slides as TIFF files from PowerPoint, it exports them with a resolution of 72 ppi, which is insufficient for print.

Now, some people use work-arounds. For example, they open the exported TIFF files in Photoshop and simply change the resolution from 72 ppi to 300 ppi (or more). But beware — there are pitfalls to going this route.

When you go to the “Image Size” box in Photoshop, you will see the “Resample” box. If this box is checked when you upscale or increase the resolution, Photoshop will keep the physical dimensions of the image the same and create additional pixels to generate a higher-resolution image. The additional pixels are created by a method called resampling, and the resulting image may therefore not appear the same as the original.

On the other hand, if you uncheck the box, the program will not create any new pixels but will instead decrease the size of the image to increase its resolution. This new image may be extremely small and may not be usable by the publisher (Figure 1).

There are some other ways of turning PowerPoint files into TIFFs, but they suffer similar drawbacks. For example, some users might take a screenshot of the PowerPoint slide and then convert the screenshot into a 300 dpi TIFF in Photoshop, but this method has the same issues as above.

Another method I’ve seen used is to save the PowerPoint as a PDF and then convert the PDF into a TIFF. This method risks compromising image quality, as certain types of PDF conversions apply a JPEG compression to the file. If you recall from my May column, JPEG compression can introduce artifacts into your images and should be avoided at all costs.

There are other work-arounds that involve changing registries or doing some conversions that I won’t get into, but the easiest way to avoid these problems from the outset is to use software intended for combining high-resolution images with vector graphics.

The bottom line is that PowerPoint is software designed to give screen presentations, not to produce publication-quality figures. In fact, the output from PowerPoint needs to go through multiple conversion steps to arrive at a final product with possibly compromised integrity. Using appropriate software, such as Illustrator or Inkscape, during figure composition will ensure you are presenting your data in the best possible way — with due diligence.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Kaoru Sakabe

Kaoru Sakabe is the data integrity manager at the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Cholesterol regulatory genes predict liver transplant outcomes
Journal News

Cholesterol regulatory genes predict liver transplant outcomes

April 10, 2026

Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Journal News

Lipid signatures for a rare neurological disorder

April 10, 2026

Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Journal News

Disease-linked mutations disrupt protein phase behavior

April 9, 2026

Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.

The dual role of asprosin in chronic fatty liver disease
Journal News

The dual role of asprosin in chronic fatty liver disease

April 8, 2026

Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.

Novel inhibitor targets RAS-driven cancers
Journal News

Novel inhibitor targets RAS-driven cancers

April 7, 2026

Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.

Catching tau in the act
Journal News

Catching tau in the act

April 2, 2026

Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.